Oral mucosal diseases: Erythema multiforme

British Journal of Oral and Maxillofacial Surgery

Volumn 46, Issue 2, 2008, Pages 90-95

  Scully, Crispian ^a   Bagan, Jose ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Autoimmune; Erythema multiforme; Immunosuppressants; Oral; Skin; Vesiculobullous

Indexed keywords

ACICLOVIR; ALLOPURINOL; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; LAMOTRIGINE; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PHENYTOIN; PREDNISOLONE; PROGESTERONE; PROTEINASE INHIBITOR; SULFONAMIDE; TETRACYCLINE; THALIDOMIDE; VALACICLOVIR;

APOPTOSIS; ARTICLE; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; DRUG DOSE REDUCTION; ERYTHEMA MULTIFORME; HERPES SIMPLEX; HUMAN; HYPERSENSITIVITY REACTION; KERATINOCYTE; ORAL MUCOSAL DISEASE; PATHOGENESIS; SKIN DEFECT; STEVENS JOHNSON SYNDROME;

ERYTHEMA MULTIFORME; GLUCOCORTICOIDS; HERPES SIMPLEX; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH DISEASES; MOUTH MUCOSA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 38949086223     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2007.07.202     Document Type: Article

References (36)

1. Williams P.M., and Conklin R.J. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis. Dent Clin North Am 49 (2005) 67-76
2. Farthing P., Bagan J.V., and Scully C. Mucosal disease series. Number IV. Erythema multiforme. Oral Dis 11 (2005) 261-267
3. Letko E., Papaliodis D.N., Papaliodis G.N., Daoud Y.J., Ahmed A.R., and Foster C.S. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 94 (2005) 419-436
4. Hussain W., and Craven N.M. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Clin Med 5 (2005) 555-558
5. Ayangco L., and Rogers III R.S. Oral manifestations of erythema multiforme. Dermatol Clin 21 (2003) 195-205
6. Carrozzo M., Togliatto M., and Gandolfo S. Eritema multiforme. Un fenotipo patologico eterogeneo. [Erythema multiforme. A heterogeneous pathologic phenotype]. Minerva Stomatol 48 (1999) 217-226
7. Farthing P.M., Maragou P., Coates M., Tatnall F., Leigh I.M., and Williams D.M. Characteristics of the oral lesions in patients with cutaneous recurrent erythema multiforme. J Oral Pathol Med 24 (1995) 9-13
8. Leigh I.M., Mowbray J.F., Levene G.M., and Sutherland S. Recurrent and continuous erythema multiforme-a clinical and immunological study. Clin Exp Dermatol 10 (1985) 58-67
9. Nesbit S.P., and Gobetti J.P. Multiple recurrence of oral erythema multiforme after secondary herpes simplex: report of case and review of literature. J Am Dent Assoc 112 (1986) 348-352
10. Huff J.C., and Weston W.L. Recurrent erythema multiforme. Medicine (Baltimore) 68 (1989) 133-140
11. Brice S.L., Krzemien D., Weston W.L., and Huff J.C. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 93 (1989) 183-187
12. Darragh T.M., Egbert B.M., Berger T.G., and Yen T.S. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 24 (1991) 23-26
13. Aslanzadeh J., Helm K.F., Espy M.J., Muller S.A., and Smith T.F. Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction. Br J Dermatol 126 (1992) 19-23
14. Miura S., Smith C.C., Burnett J.W., and Aurelian L. Detection of viral DNA within skin of healed recurrent herpes simplex infection and erythema multiforme lesions. J Invest Dermatol 98 (1992) 68-72
15. Imafuku S., Kokuba H., Aurelian L., and Burnett J. Expression of herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. J Invest Dermatol 109 (1997) 550-556
16. Kokuba H., Imafuku S., Burnett J.W., and Aurelian L. Longitudinal study of a patient with herpes-simplex-virus-associated erythema multiforme: viral gene expression and T cell repertoire usage. Dermatology 198 (1999) 233-242
17. Sun Y., Chan R.K., Tan S.H., and Ng P.P. Detection and genotyping of human herpes simplex viruses in cutaneous lesions of erythema multiform by nested PCR. J Med Virol 71 (2003) 423-428
18. Abdollahi M., and Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract 4 (2003) 10-31
19. Scully C., and Bagan J.V. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 15 (2004) 221-239
20. Diz Dios P., and Scully C. Adverse effects of antiretroviral therapy: focus on orofacial effects. Expert Opin Drug Saf 1 (2002) 307-317
21. Lin M.S., Dai Y.S., Pwu R.F., Chen Y.H., and Chang N.C. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Intern Med J 35 (2005) 188-190
22. Stewart M.G., Duncan III N.O., Franklin D.J., Friedman E.M., and Sulek M. Head and neck manifestations of erythema multiforme in children. Otolaryngol Head Neck Surg 111 (1994) 236-242
23. Wohrl S., Loewe R., Pickl W.F., Stingl G., and Wagner S.N. EMPACT syndrome. J Dtsch Dermatol Ges 3 (2005) 39-43
24. Ono F., Sharma B.K., Smith C.C., Burnett J.W., and Aurelian L. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 124 (2005) 1215-1224
25. Malmstrom M., Ruokonen H., Konttinen Y.T., Bergroth V., Segerberg-Konttinen M., Hietanen J., et al. Herpes simplex virus antigens and inflammatory cells in oral lesions in recurrent erythema multiforme. Immunoperoxidase and autoradiographic studies. Acta Derm Venereol 70 (1990) 405-410
26. Kokuba H., Imafuku S., Huang S., Aurelian L., and Burnett J.W. Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response. Br J Dermatol 138 (1998) 952-964
27. Knowles S.R., Uetrecht J., and Shear N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 356 (2000) 1587-1591
28. Paul C., Wolkenstein P., Adle H., et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134 (1996) 710-714
29. Caproni M., Torchia D., Schincaglia E., et al. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol 154 (2006) 319-324
30. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schroder W., and Roujeau J.C. Correlations between clinical patterns and causes of erythema multiforme majus. Stevens-Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138 (2002) 1019-1024
31. Huff J.C., Weston W.L., and Tonnesen M.G. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 8 (1983) 763-775
32. de Roux Serratrice C., Serratrice J., Granel B., et al. Syndrome de Stevens-Johnson suivi d'un syndrome de Gougerot-Sjogren. [Stevens-Johnson syndrome followed by Gougerot-Sjogren syndrome]. Presse Med 30 (2001) 531-532
33. Schofield J.K., Tatnall F.M., and Leigh I.M. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 128 (1993) 542-545
34. Conejo-Mir J.S., del Canto S., Munoz M.A., et al. Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. J Drugs Dermatol 2 (2003) 40-44
35. Geraminejad P., Walling H.W., Voigt M.D., and Stone M.S. Severe erythema multiforme responding to interferon alfa. J Am Acad Dermatol 54 Suppl (2006) S18-S21
36. Bakis S., and Zagarella S. Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme. Australas J Dermatol 46 (2005) 18-20